Synthetic routes yield new gold-selenolato complexes, demonstrating potential as anticancer agents in cancer models.
Two distinct synthetic pathways are disclosed that lead to new coinage metal-selenolato complexes, stabilized by N-heterocyclic carbenes (NHCs). The weak base route can provide facile access to phenylselenolate complexes of...
No takes yet. Share an insight, caveat, or question.
Arnaut et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: